Cengiz Gokcek Women's and Children's Hospital
15
0
0
9
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 15 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 9 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (15)
Magnesium and Vanadium Levels in Preeclampsia
Role: lead
Incidence, Risk Factors and Severity of Retinopathy of Prematurity (ROP) in Turkey
Role: collaborator
Levels of Selected Microelements in Premature Ovarian Insufficiency
Role: lead
Metals and in Fetal Growth Restriction
Role: lead
Levels of Selected Macroelements in Premature Ovarian Insufficiency
Role: lead
Metals/Vitamins Levels in NTD
Role: lead
sFlt- 1, PIGF, and Niacin Levels in Women With Premature Ovarian Insufficiency
Role: lead
Melatonin, Soluble Urokinase-type Plasminogen Activator Receptor, and Orosomucoid 2 Levels in PPROM
Role: lead
Matrix Metalloproteinase 14, Neopterin, and Orosomucoid 1 Levels in PPROM
Role: lead
Thiol/Disulphide Homeostasis and Preeclampsia
Role: lead
Vanadium in Late-onset Preeclampsia
Role: lead
Analyses of Interleukin-6, Presepsin and Pentraxin-3 in the Diagnosis and Severity of Late-onset Preeclampsia
Role: lead
Trace Elements and Heavy Metals at PPROM
Role: lead
Serum Soluble Endoglin and Matrix Metalloproteinase 14 With Elisa Method in Early/Late-onset Preeclampsia
Role: lead
Endocan Levels in Women With Premature Ovarian Insufficiency
Role: lead
All 15 trials loaded